Visinpro Tablets 45mg, containing Dacomitinib hydrate, are manufactured by Pfizer. This medication (YJ code: 4291056F2021, 45mg 1 tablet) is primarily indicated for specific forms of non-small cell lung cancer (NSCLC).
Visinpro Tablets 45mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →